Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Pluristem Takes Possession of and Moving Into New State-of-the-Art Manufacturing Facility 


January 30, 2013 - (Pluristem) - "Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the company has taken possession of and is moving into its new state-of-the-art GMP facility. The facility allows for the production of mass quantities of PLacental eXpanded (PLX) cells that possess the advantages of being grown utilizing Pluristem's patented 3D bioreactor technology." Read Full Press Release


Posted on 4-Feb-13 by Gallerno, Jacob
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: